Publicacións nas que colabora con David Brea López (23)

2015

  1. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  2. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Increased expression of Toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage

    Journal of Neuroimmunology, Vol. 247, Núm. 1-2, pp. 75-80

  3. Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1788-1793

  4. Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies

    Journal of Vascular and Interventional Radiology, Vol. 23, Núm. 6, pp. 818-824

2011

  1. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke

    Neurological Research, Vol. 33, Núm. 6, pp. 572-577

  2. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  3. Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico

    Revista de Neurologia, Vol. 52, Núm. 1, pp. 12-19

  4. Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients

    Neurological Research, Vol. 33, Núm. 10, pp. 1057-1063

  5. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

  6. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1424-1431

  7. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

2009

  1. High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage

    Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 12, pp. 1968-1974

  2. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke

    Disease Markers, Vol. 26, Núm. 4, pp. 189-195

  3. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke

    Clinical Chemistry and Laboratory Medicine, Vol. 47, Núm. 12, pp. 1513-1518

  4. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation

    Atherosclerosis, Vol. 205, Núm. 2, pp. 561-567